Literature DB >> 6457438

The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs. II. Pathology.

D M Hoover, W W Carlton.   

Abstract

The lesions caused by excess oral pyridoxine hydrochloride (150 mg/kg body weight/day) and clioquinol (200 mg/kg body weight/day), given individually and in combination to adult Beagle dogs, were evaluated. The experimental period was 100 to 112 days, except that four dogs in each of the clioquinol and combined-treatment groups were killed early because of severe debilitation or neurologic disease, and one dog given both compounds died on the third day of compound administration. Degenerative neurologic lesions had distribution specific for the compound given. Pyridoxine-treated dogs had lesions limited to tracts and nerves with neuronal bodies of their nerve fibers in the spinal and trigeminal ganglia. Clioquinol-treated dogs had neurologic lesions limited to the central nervous system. The most lesions were in the rostral dorsal funiculus and distal aspects of the optic nerve fibers, but minimal to mild degenerative changes also occurred in distal aspects of the corticospinal and spinocerebellar tracts. Dogs given both pyridoxine hydrochloride and clioquinol had a combination of the lesions in dogs given pyridoxine or clioquinol individually. Several dogs given clioquinol or pyridoxine plus clioquinol had extraneural lesions, including myocardial degeneration and thyroidal alterations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457438     DOI: 10.1177/030098588101800606

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  6 in total

1.  The cardioprotective compound cloxyquin uncouples mitochondria and induces autophagy.

Authors:  Jimmy Zhang; Sergiy M Nadtochiy; William R Urciuoli; Paul S Brookes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-30       Impact factor: 4.733

2.  Alteration of neuronal cytoskeletal organization in dorsal root ganglia associated with pyridoxine neurotoxicity.

Authors:  V J Montpetit; D F Clapin; L Tryphonas; S Dancea
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Control of Mammalian Locomotion by Somatosensory Feedback.

Authors:  Alain Frigon; Turgay Akay; Boris I Prilutsky
Journal:  Compr Physiol       Date:  2021-12-29       Impact factor: 8.915

4.  SP, CGRP changes in pyridoxine induced neuropathic dogs with nerve growth factor gene therapy.

Authors:  Joo-Yeon Kang; Dae Young Yoo; Kwon-Young Lee; Wooseok Im; Manho Kim; Jung Hoon Choi; Hwa-Young Youn; Sae Hoon Kim; In Koo Hwang; Jin-Young Chung
Journal:  BMC Neurosci       Date:  2016-01-05       Impact factor: 3.288

5.  Pyridoxine induced neuropathy by subcutaneous administration in dogs.

Authors:  Jin-Young Chung; Jung-Hoon Choi; Cheol-Yong Hwang; Hwa-Young Youn
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672

6.  In vitro and in vivo gene therapy with CMV vector-mediated presumed dog beta-nerve growth factor in pyridoxine-induced neuropathy dogs.

Authors:  Jin Young Chung; Jung Hoon Choi; Il Seob Shin; Eun Wha Choi; Cheol Yong Hwang; Sang Koo Lee; Hwa Young Youn
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.